Activating transcription factor 4 confers a multidrug resistance phenotype to gastric cancer cells through transactivation of SIRT1 expression.

PloS One
Hongwu ZhuKaichun Wu

Abstract

Multidrug resistance (MDR) in gastric cancer remains a major challenge to clinical treatment. Activating transcription factor 4 (ATF4) is a stress response gene involved in homeostasis and cellular protection. However, the expression and function of ATF4 in gastric cancer MDR remains unknown. In this study, we investigate whether ATF4 play a role in gastric cancer MDR and its potential mechanisms. We demonstrated that ATF4 overexpression confered the MDR phenotype to gastric cancer cells, while knockdown of ATF4 in the MDR variants induced re-sensitization. In this study we also showed that the NAD(+)-dependent histone deacetylase SIRT1 was required for ATF4-induced MDR effect in gastric cancer cells. We demonstrated that ATF4 facilitated MDR in gastric cancer cells through direct binding to the SIRT1 promoter, resulting in SIRT1 up-regulation. Significantly, inhibition of SIRT1 by small interfering RNA (siRNA) or a specific inhibitor (EX-527) reintroduced therapeutic sensitivity. Also, an increased Bcl-2/Bax ratio and MDR1 expression level were found in ATF4-overexpressing cells. We showed that ATF4 had a key role in the regulation of MDR in gastric cancer cells in response to chemotherapy and these findings suggest that targe...Continue Reading

References

May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·Y S Lin, M R Green
Apr 25, 1994·Nucleic Acids Research·D M Benbrook, N C Jones
Jan 1, 1997·Annual Review of Biochemistry·M Montminy
Nov 14, 1997·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·H A LehrA M Gown
Sep 28, 1998·Biochimica Et Biophysica Acta·A K Larsen, A Skladanowski
Mar 31, 2000·Pharmacology & Therapeutics·A K LarsenA Skladanowski
Nov 20, 2002·The Journal of Clinical Investigation·David Ron
Apr 12, 2003·Developmental Cell·D Thomas Rutkowski, Randal J Kaufman
Jul 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Krishna M Vattem, Ronald C Wek
Mar 19, 2005·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Nobuko MatsushitaMinoru Takata
Oct 5, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T R WilsonP G Johnston
May 1, 2007·The International Journal of Biochemistry & Cell Biology·Kurosh Ameri, Adrian L Harris
Oct 20, 2007·Expert Review of Anticancer Therapy·Dexin Zhang, Daiming Fan
Jun 25, 2008·Biochemical and Biophysical Research Communications·Keitaro KojimaMasafumi Ito
Aug 19, 2008·Molecular Cancer Research : MCR·Jenilyn J VirreyAmy S Lee
Aug 30, 2008·Molecular Cancer Research : MCR·Xing-Jie LiangMichael M Gottesman
May 13, 2009·The Journal of Biological Chemistry·Neha KabraJiandong Chen
Nov 6, 2009·Cell Cycle·Tomasz RzymskiAdrian L Harris
Jan 19, 2010·Annual Review of Pathology·Marcia C Haigis, David A Sinclair
Jun 2, 2010·Oncogene·T RzymskiA L Harris
Jun 10, 2010·Cancer Research·Janai R CarrPradip Raychaudhuri
Jan 5, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Yolanda OlmosEric W-F Lam

❮ Previous
Next ❯

Citations

Aug 1, 2013·World Journal of Gastroenterology : WJG·Qi LiuShao-Lin Nie
Mar 31, 2015·Molecular Medicine Reports·Wei ZhaoXiang-Ming Che
Oct 30, 2012·Free Radical Biology & Medicine·Brian J Morris
Dec 5, 2014·Pharmaceutical Biology·Yong-Dong JinJin Lu
Jan 6, 2018·Biomedicines·Ilya O VelegzhaninovOlesya M Vakhrusheva
Jun 23, 2018·Epigenomics·Nabil HajjiNelofer Syed
Feb 19, 2014·International Journal of Oncology·Chutima KaewpiboonYoung-Hwa Chung
Sep 4, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Marcin BulerJukka Hakkola
Jul 29, 2016·World Journal of Gastroenterology : WJG·Ya-Ling HuZhao-Hui Huang
Dec 3, 2016·Cell Death and Differentiation·Alexandre ProlaChristophe Lemaire
Jul 18, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adrián González-GonzálezSergio Granados-Principal

❮ Previous
Next ❯

Methods Mentioned

BETA
chemical treatments
ChIP
transfection
FACS
electrophoresis
PCR
immunoprecipitation
Assay

Software Mentioned

Tfsitescan service
Genomatix
TESS
SPSS16

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.